TRONCI, ELISABETTA
 Distribuzione geografica
Continente #
EU - Europa 78.280
NA - Nord America 2.798
AS - Asia 367
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 81.457
Nazione #
IT - Italia 77.523
US - Stati Uniti d'America 2.782
CN - Cina 260
UA - Ucraina 244
DE - Germania 180
SE - Svezia 164
FI - Finlandia 60
GB - Regno Unito 53
SG - Singapore 50
KR - Corea 25
CA - Canada 16
RU - Federazione Russa 16
VN - Vietnam 12
BE - Belgio 11
FR - Francia 11
IN - India 8
CZ - Repubblica Ceca 6
NL - Olanda 6
HK - Hong Kong 5
BR - Brasile 4
EU - Europa 3
CL - Cile 2
IE - Irlanda 2
JP - Giappone 2
TH - Thailandia 2
TR - Turchia 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
LV - Lettonia 1
MT - Malta 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 81.457
Città #
Cagliari 77.355
Fairfield 420
Woodbridge 360
Ashburn 216
Chandler 212
Ann Arbor 201
Houston 182
Wilmington 179
Cambridge 151
Seattle 151
Jacksonville 126
Nyköping 126
Dearborn 108
Shanghai 53
Nanjing 52
Beijing 49
Boardman 33
Helsinki 25
Boston 23
New York 23
San Diego 22
Seoul 22
Singapore 17
Milan 15
Dong Ket 12
Brussels 11
Guangzhou 11
Nanchang 11
Redwood City 11
Verona 11
Mountain View 10
Shenyang 10
Changsha 9
Hebei 9
Sassari 9
Norwalk 8
Oristano 8
Toronto 8
Falls Church 7
Brno 6
Hefei 6
Los Angeles 6
Padova 6
Central 5
Jinan 5
Rome 5
Tianjin 5
Washington 5
Edinburgh 4
Florence 4
Grottammare 4
Hangzhou 4
Jiaxing 4
London 4
Ningbo 4
Orange 4
Phoenix 4
Pune 4
Borås 3
Detroit 3
Kilburn 3
Tossicia 3
Zhengzhou 3
Ankara 2
Atlanta 2
Auburn Hills 2
Augusta 2
Baotou 2
Brescia 2
Capoterra 2
Chicago 2
Dublin 2
Fuzhou 2
Kunming 2
Munich 2
Ottawa 2
Palermo 2
Redmond 2
San Vittore Olona 2
Sarroch 2
Siena 2
Uta 2
Villacidro 2
Yellow Springs 2
Bangalore 1
Bay Springs 1
Berlin 1
Clifton 1
Council Bluffs 1
Este 1
Ferrara 1
Forest City 1
Genoa 1
Indiana 1
Lanzhou 1
Leawood 1
Monmouth Junction 1
Montreal 1
Perth 1
Prescot 1
Totale 80.428
Nome #
Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. 4.085
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 4.043
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction 3.885
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 3.818
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia 3.492
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.331
Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats 3.289
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation 3.201
null 2.940
Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats 2.663
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia 2.408
The serotonergic system in levodopa-induced dyskinesia 2.373
null 2.298
null 2.247
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.093
5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation 2.029
Foetal cell transplantation for Parkinson's disease: focus on graft-induced dyskinesia 2.021
Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: A correlation study 2.005
Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations 1.964
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 1.947
Role of serotonin neurons in L-DOPA- and graft-induced dyskinesia in a rat model of parkinson's disease 1.917
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.614
null 1.471
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and5-HT1B receptor agonists in the rat Parkinson model 1.419
Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress 1.222
null 1.194
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.155
BDNF Overexpression Increases Striatal D3Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia 1.155
Caffeine sensitization and cross-sensitization with amphetamine: association to post-synaptic changes in rat striatal neurons 1.122
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats 1.015
null 1.012
Dopamine and adenosine receptor interaction as the basis for the treatment of Parkinson's disease 973
null 967
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 963
CAFFEINE SESITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS 955
CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURON 925
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dyskinesia 886
Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease 834
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dynskinesia 826
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 812
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 808
Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment 765
5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model 700
BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats 463
Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons 181
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats 144
Totale 81.630
Categoria #
all - tutte 93.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013.984 0 0 108 215 6.088 3.863 2.038 385 314 297 254 422
2020/202120.096 744 705 817 5.643 4.256 2.287 1.509 1.263 366 959 961 586
2021/20223.592 394 366 173 182 253 273 204 158 271 431 492 395
2022/20235.396 358 594 582 451 475 603 302 358 408 422 567 276
2023/20245.792 231 177 232 295 539 859 907 389 223 409 613 918
2024/202510.879 4.890 4.650 1.339 0 0 0 0 0 0 0 0 0
Totale 81.630